ELYUNATE

Serial Number 86001891
606

Registration Progress

Application Filed
Jul 3, 2013
Under Examination
Jan 14, 2014
Approved for Publication
Nov 19, 2013
Published for Opposition
Nov 19, 2013
Registered

Trademark Image

ELYUNATE

Basic Information

Serial Number
86001891
Filing Date
July 3, 2013
Published for Opposition
November 19, 2013
Abandonment Date
February 20, 2017
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Feb 20, 2017
Classes
005

Rights Holder

Eli Lilly and Company

03
Address
Lilly Corporate Center
Indianapolis, IN 46285

Ownership History

Eli Lilly and Company

Original Applicant
03
Indianapolis, IN

Eli Lilly and Company

Owner at Publication
03
Indianapolis, IN

Legal Representation

Attorney
Robert E. Lee, Jr.

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

31 events
Date Code Type Description Documents
Feb 21, 2017 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Feb 20, 2017 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jul 15, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 14, 2016 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jun 28, 2016 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 28, 2016 EXT5 S SOU EXTENSION 5 FILED Loading...
Sep 23, 2015 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 22, 2015 EX4G S SOU EXTENSION 4 GRANTED Loading...
Sep 18, 2015 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 18, 2015 EXT4 S SOU EXTENSION 4 FILED Loading...
Jul 15, 2015 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 14, 2015 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jul 1, 2015 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 1, 2015 EXT3 S SOU EXTENSION 3 FILED Loading...
Feb 3, 2015 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 2, 2015 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jan 30, 2015 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Dec 12, 2014 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 12, 2014 EXT2 S SOU EXTENSION 2 FILED Loading...
Jun 12, 2014 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 10, 2014 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 10, 2014 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 10, 2014 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 14, 2014 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 19, 2013 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 19, 2013 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 30, 2013 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 8, 2013 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 2, 2013 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 15, 2013 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 6, 2013 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, Parkinson's disease, psychiatric disorders, sleep disorders, urological disorders; antidepressants; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005